Amaia Calderón-Larrañaga

Summary

Affiliation: Hospital Universitario Miguel Servet
Country: Spain

Publications

  1. pmc Multimorbidity patterns in primary care: interactions among chronic diseases using factor analysis
    Alexandra Prados-Torres
    IIS Aragón, Aragon Health Sciences Institute, Miguel Servet University Hospital, University of Zaragoza, Zaragoza, Spain
    PLoS ONE 7:e32190. 2012
  2. pmc Polypharmacy Patterns: Unravelling Systematic Associations between Prescribed Medications
    Amaia Calderón-Larrañaga
    EpiChron Research Group on Chronic Diseases, Aragón Health Sciences Institute IACS, IIS Aragón, Miguel Servet University Hospital, Zaragoza, Spain Department of Microbiology, Preventive Medicine and Public Health, University of Zaragoza, Zaragoza, Spain Red de investigación en servicios de salud en enfermedades crónicas REDISSEC, Carlos III Health Institute, Madrid, Spain Teaching Unit of Preventive Medicine and Public Health, Aragón Health Sciences Institute IACS, IIS Aragón, Zaragoza, Spain
    PLoS ONE 8:e84967. 2013
  3. pmc Primary care utilisation patterns among an urban immigrant population in the Spanish National Health System
    Amaia Calderón-Larrañaga
    Instituto Aragones de Ciencias de la Salud, Instituto de Investigación Sanitaria Aragón, Zaragoza, Spain
    BMC Public Health 11:432. 2011
  4. doi request reprint Comorbidity of dementia: a cross-sectional study of primary care older patients
    Beatriz Poblador-Plou
    EpiChron Research Group on Chronic Diseases, Aragón Health Sciences Institute IACS, IIS Aragón, Miguel Servet University Hospital, Zaragoza, Spain
    BMC Psychiatry 14:84. 2014
  5. pmc Multimorbidity, polypharmacy, referrals, and adverse drug events: are we doing things well?
    Amaia Calderón-Larrañaga
    Aragón Health Sciences Institute IACS, IIS Aragón, Miguel Servet University Hospital, University of Zaragoza, Spain
    Br J Gen Pract 62:e821-6. 2012
  6. pmc Does the pharmacy expenditure of patients always correspond with their morbidity burden? Exploring new approaches in the interpretation of pharmacy expenditure
    Amaia Calderón-Larrañaga
    Aragon Health Sciences Institute I CS, Zaragoza, Spain
    BMC Public Health 10:244. 2010
  7. pmc Applying diagnosis and pharmacy-based risk models to predict pharmacy use in Aragon, Spain: the impact of a local calibration
    Amaia Calderón-Larrañaga
    Aragon Health Science Institute, 25, Gomez Laguna Ave, Zaragoza 50009, Spain
    BMC Health Serv Res 10:22. 2010
  8. doi request reprint Underreporting of recognized adverse drug reactions by primary care physicians: an exploratory study
    Francisca González-Rubio
    Instituto Aragones de Ciencias de la Salud I CS, Instituto de Investigación Sanitaria Aragón IIS Aragón, Zaragoza, Spain
    Pharmacoepidemiol Drug Saf 20:1287-94. 2011
  9. ncbi request reprint Age and gender differences in the prevalence and patterns of multimorbidity in the older population
    José María Abad-Díez
    Department of Health Wellbeing and Family, Government of Aragon, Zaragoza, Spain
    BMC Geriatr 14:75. 2014
  10. doi request reprint Multimorbidity patterns: a systematic review
    Alexandra Prados-Torres
    EpiChron Research Group on Chronic Diseases, Aragón Health Sciences Institute IACS, IIS Aragón, Miguel Servet University Hospital, pl 2, paseo Isabel la Catolica 1 3, 50009, Zaragoza, Spain Department of Microbiology, Preventive Medicine and Public Health, University of Zaragoza, Facultad de Medicina, C Domingo Miral s n, 50009, Zaragoza, Spain Red de investigación en servicios de salud en enfermedades crónicas REDISSEC, Carlos III Health Institute, Madrid, Spain Teaching Unit of Preventive Medicine and Public Health, Aragón Health Sciences Institute IACS, IIS Aragón, Edificio CIBA, Avda San Juan Bosco 13, 50009, Zaragoza, Spain Electronic address
    J Clin Epidemiol 67:254-66. 2014

Collaborators

Detail Information

Publications12

  1. pmc Multimorbidity patterns in primary care: interactions among chronic diseases using factor analysis
    Alexandra Prados-Torres
    IIS Aragón, Aragon Health Sciences Institute, Miguel Servet University Hospital, University of Zaragoza, Zaragoza, Spain
    PLoS ONE 7:e32190. 2012
    ..The secondary objective of this study was to generate evidence regarding the pathophysiological processes underlying multimorbidity and to understand the interactions and synergies among the various diseases...
  2. pmc Polypharmacy Patterns: Unravelling Systematic Associations between Prescribed Medications
    Amaia Calderón-Larrañaga
    EpiChron Research Group on Chronic Diseases, Aragón Health Sciences Institute IACS, IIS Aragón, Miguel Servet University Hospital, Zaragoza, Spain Department of Microbiology, Preventive Medicine and Public Health, University of Zaragoza, Zaragoza, Spain Red de investigación en servicios de salud en enfermedades crónicas REDISSEC, Carlos III Health Institute, Madrid, Spain Teaching Unit of Preventive Medicine and Public Health, Aragón Health Sciences Institute IACS, IIS Aragón, Zaragoza, Spain
    PLoS ONE 8:e84967. 2013
    ..The aim of this study was to demonstrate the existence of systematic associations in drug prescription that lead to the establishment of patterns of polypharmacy, and the clinical interpretation of the associations found in each pattern...
  3. pmc Primary care utilisation patterns among an urban immigrant population in the Spanish National Health System
    Amaia Calderón-Larrañaga
    Instituto Aragones de Ciencias de la Salud, Instituto de Investigación Sanitaria Aragón, Zaragoza, Spain
    BMC Public Health 11:432. 2011
    ..This study takes a step forward to compare primary care (PC) utilisation patterns between immigrants and the native population with regard to their morbidity burden...
  4. doi request reprint Comorbidity of dementia: a cross-sectional study of primary care older patients
    Beatriz Poblador-Plou
    EpiChron Research Group on Chronic Diseases, Aragón Health Sciences Institute IACS, IIS Aragón, Miguel Servet University Hospital, Zaragoza, Spain
    BMC Psychiatry 14:84. 2014
    ....
  5. pmc Multimorbidity, polypharmacy, referrals, and adverse drug events: are we doing things well?
    Amaia Calderón-Larrañaga
    Aragón Health Sciences Institute IACS, IIS Aragón, Miguel Servet University Hospital, University of Zaragoza, Spain
    Br J Gen Pract 62:e821-6. 2012
    ..The consequences of multimorbidity include polypharmacy and repeated referrals for specialised care, which may increase the risk of adverse drug events (ADEs)...
  6. pmc Does the pharmacy expenditure of patients always correspond with their morbidity burden? Exploring new approaches in the interpretation of pharmacy expenditure
    Amaia Calderón-Larrañaga
    Aragon Health Sciences Institute I CS, Zaragoza, Spain
    BMC Public Health 10:244. 2010
    ..We paid special attention to the identification of individuals who had higher values of pharmacy expenditure than their morbidity would otherwise suggest (i.e. outliers)...
  7. pmc Applying diagnosis and pharmacy-based risk models to predict pharmacy use in Aragon, Spain: the impact of a local calibration
    Amaia Calderón-Larrañaga
    Aragon Health Science Institute, 25, Gomez Laguna Ave, Zaragoza 50009, Spain
    BMC Health Serv Res 10:22. 2010
    ..Developed primarily for the U.S. health care setting, a secondary objective was to evaluate the benefit of a local calibration in order to adapt the PMs to the Spanish health care system...
  8. doi request reprint Underreporting of recognized adverse drug reactions by primary care physicians: an exploratory study
    Francisca González-Rubio
    Instituto Aragones de Ciencias de la Salud I CS, Instituto de Investigación Sanitaria Aragón IIS Aragón, Zaragoza, Spain
    Pharmacoepidemiol Drug Saf 20:1287-94. 2011
    ....
  9. ncbi request reprint Age and gender differences in the prevalence and patterns of multimorbidity in the older population
    José María Abad-Díez
    Department of Health Wellbeing and Family, Government of Aragon, Zaragoza, Spain
    BMC Geriatr 14:75. 2014
    ..We sought to describe age and gender differences in the prevalence and patterns of multimorbidity in men and women over 65 years...
  10. doi request reprint Multimorbidity patterns: a systematic review
    Alexandra Prados-Torres
    EpiChron Research Group on Chronic Diseases, Aragón Health Sciences Institute IACS, IIS Aragón, Miguel Servet University Hospital, pl 2, paseo Isabel la Catolica 1 3, 50009, Zaragoza, Spain Department of Microbiology, Preventive Medicine and Public Health, University of Zaragoza, Facultad de Medicina, C Domingo Miral s n, 50009, Zaragoza, Spain Red de investigación en servicios de salud en enfermedades crónicas REDISSEC, Carlos III Health Institute, Madrid, Spain Teaching Unit of Preventive Medicine and Public Health, Aragón Health Sciences Institute IACS, IIS Aragón, Edificio CIBA, Avda San Juan Bosco 13, 50009, Zaragoza, Spain Electronic address
    J Clin Epidemiol 67:254-66. 2014
    ....
  11. ncbi request reprint Similar multimorbidity patterns in primary care patients from two European regions: results of a factor analysis
    Beatriz Poblador-Plou
    EpiChron Research Group on Chronic Diseases, Aragón Health Sciences Institute IACS, IIS Aragón, Miguel Servet University Hospital, Zaragoza, Spain Red de investigación en servicios de salud en enfermedades crónicas REDISSEC, Carlos III Health Institute, Madrid, Spain Teaching Unit of Preventive Medicine and Public Health, Aragón Health Sciences Institute IACS, IIS Aragón, Zaragoza, Spain
    PLoS ONE 9:e100375. 2014
    ....
  12. pmc Pharmaceutical cost control in primary care: opinion and contributions by healthcare professionals
    Alexandra Prados-Torres
    Instituto Aragones de Ciencias de la Salud, Zaragoza, Espana
    BMC Health Serv Res 9:209. 2009
    ..This study collects and analyzes the opinions of general practitioners (GPs) regarding current cost control measures as well as their proposals for improving the effectiveness of these measures...